February 27, 2020 / 11:13 PM / a month ago

BRIEF-Nuvo Pharmaceuticals Announces Health Canada Approves Suvexx For Acute Treatment Of Migraine

Feb 27 (Reuters) - Nuvo Pharmaceuticals Inc:

* NUVO PHARMACEUTICALS® ANNOUNCES HEALTH CANADA APPROVES SUVEXX™ FOR THE ACUTE TREATMENT OF MIGRAINE

* NUVO PHARMACEUTICALS INC - CANADIAN LAUNCH ANTICIPATED IN SECOND HALF OF 2020 Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below